University of Minnesota COVID-19 study finds benefit from metformin, not ivermectin - Star Tribune

Ivermectin, a cheap anti-parasitic drug, has strong advocates, but showed no statistically significant benefit against COVID-19 in a U trial.

COVID-19 patients were less likely to die or need hospital care if they took the common anti-diabetes drug metformin, according to a long-awaited University of Minnesota study, but not if they took i… [+5568 chars]

full article...